Literature DB >> 6601169

Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

C C Sanders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6601169     DOI： 10.1093/infdis/147.3.585

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  49 in total

1.  Effects of a restrictive antibiotic policy on clinical efficacy of antibiotics and susceptibility patterns of organisms.

Authors:  A W Sturm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

2.  The influence of clinical use of antibiotics and the sensitivity of strains isolated from postoperative infections--a comparison of nosocomial pathogens with strains isolated from the bacterial flora of patients.

Authors:  Y Takesue; T Yokoyama; T Kodama; Y Murakami; H Sewake; K Miyamoto; Y Imamura; H Tsumura; Y Matsuura
Journal:  Jpn J Surg       Date:  1991-07

3.  Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.

Authors:  H Nikaido; W Liu; E Y Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

4.  Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert; Y Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

5.  Cell surface changes in Pseudomonas aeruginosa PAO4069 in response to treatment with 6-aminopenicillanic acid.

Authors:  A J Godfrey; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

6.  Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.

Authors:  A S Bayer; P Lindsay; J Yih; L Hirano; D Lee; I K Blomquist
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

7.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

8.  Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.

Authors:  L R Peterson; D N Gerding; J A Moody; C E Fasching
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

9.  Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.

Authors:  M A Bertram; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

10.  In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients.

Authors:  H R Stutman; D F Welch; R K Scribner; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.